Derivative Financial Instruments

We account for derivative financial instruments in accordance with the ASC guidance on “Derivatives and Hedging”. This ASC requires us to recognize the value of derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated as a hedge and qualifies as part of a hedging relationship. The accounting also depends on the type of hedging relationship, whether a cash flow hedge, a fair value hedge, or hedge of a net investment in a foreign operation. On entry into a derivative instrument, we formally designate and document it as a hedge of a specific underlying exposure, as well as the risk management objectives and strategies for undertaking the hedge transaction.

Derivatives are recorded in our Consolidated Balance Sheets at fair value in prepaid expenses and other current assets, other non-current assets, accounts payable and accrued expenses or other non-current liabilities, depending on whether the amount is an asset or liability and whether it is short-term or long-term in nature. The fair values of derivatives used to hedge or modify our risks fluctuate over time. These fair value amounts should not be viewed in isolation, but rather in relation to the cash flows or fair value of the underlying hedged transactions or assets and other exposures, as well as the overall reduction in our risk. In addition, the earnings impact resulting from our derivative instruments is recorded in the same line item within the Consolidated Statements of Income as the underlying exposure being hedged.

We predominantly designate our hedges as cash flow hedges. A cash flow hedge requires that the effective portion of the change in the fair value of a derivative instrument be recognized in other comprehensive income, a component of shareholders’ equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The ineffective portion of the change in fair value of a derivative instrument is to be recognized in earnings in the same line in which the hedge transaction affects earnings.

Counterparties expose us to credit losses in the event of non-performance on hedges. We monitor our exposure to counterparty non-performance risk both at inception of the hedge and at least quarterly thereafter. However, because these contracts are entered into with highly rated financial institutions, we do not anticipate non-performance by any of the counterparties. The exposure is usually the amount of the unrealized gains, if any, in such contracts.

Because of the high degree of effectiveness between the hedging instrument and the underlying exposure being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the cash flows or fair value of the underlying exposures being hedged. In addition, we perform an assessment of hedge effectiveness, both at inception and at least quarterly thereafter, in order to determine whether the financial instruments that are used in hedging transactions are effective at offsetting changes in the cash flows or fair value of the related underlying exposures. Any ineffective portion of a financial instrument’s change in fair value is immediately recognized in earnings.

Foreign Currency Hedges

We are exposed to fluctuations in currency exchange rates against the U.S. dollar on our results of operations and financial condition and we mitigate that exposure by entering into foreign currency forward contracts. Certain of our subsidiaries periodically enter into foreign currency forward contracts in order to hedge portions of forecasted sales or cost of sales denominated in foreign currencies, which generally expire within one year. Our foreign currency hedges were entered into for the purpose of hedging portions of our 2017 foreign currency exposure.

The foreign currency forward contracts qualifying as cash flow hedges were designated as single-purpose cash flow hedges of forecasted cash flows. Based on our formal assessment of hedge effectiveness of our qualifying foreign currency forward contracts, we determined that the impact of hedge ineffectiveness was de minimis for the quarters and six months ended June 30, 2017 and July 1, 2016.

16. Derivative Financial Instruments (continued)

We had the following outstanding foreign currency forward contracts as of June 30, 2017 (in millions):



Foreign currency contracts qualifying as cash flow hedges:	Notional amount
Euro	EUR	59.6
British pound	GBP	3.1
Japanese yen	JPY	1,496.5
Korean Won	KRW	10,635.8

The following table reflects the fair values of derivative instruments, all of which are designated as Level 2 in the fair value hierarchy, as of June 30, 2017 and December 30, 2016 (U.S. dollars in millions):



Derivatives designated as hedging instruments ⁽¹⁾
	Foreign exchange contracts
Balance Sheet location:	June 30, 2017 ⁽²⁾		December 30, 2016
Asset derivatives:
Prepaid expenses and other current assets	$	0.6	$	5.4
Total asset derivatives	$	0.6	$	5.4

Liability derivatives:
Accounts payable and accrued expenses	$	1.6	$	—
Total liability derivatives	$	1.6	$	—

⁽¹⁾ See Note 17, "Fair Value Measurements", for fair value disclosures.

⁽²⁾ We expect that $1.0 million of the net fair value of hedges recognized as a loss in accumulated other comprehensive income ("AOCI") will be transferred to earnings during the next 12 months, along with the earnings effect of the related forecasted transactions.

16. Derivative Financial Instruments (continued)

The following table reflects the effect of derivative instruments on the Consolidated Statements of Income for the quarters and six months ended June 30, 2017 and July 1, 2016 (U.S. dollars in millions):



Derivatives in effective cash flow hedging relationships	Amount of (loss) gain recognized in other comprehensive income on derivatives (effective portion)						Location of gain (loss) reclassified from AOCI into income (effective portion)	Amount of gain reclassified from AOCI into income (effective portion)
	Quarter ended							Quarter ended
	June 30, 2017			July 1, 2016				June 30, 2017		July 1, 2016
Foreign exchange contracts	$	(4.1	)	$	0.6		Net sales	$	0.5	$	0.8
Foreign exchange contracts	0.3			(0.3		)	Cost of products sold	0.1		0.1
Total	$	(3.8	)	$	0.3			$	0.6	$	0.9

	Six months ended							Six months ended
	June 30, 2017			July 1, 2016				June 30, 2017		July 1, 2016
Foreign exchange contracts	$	(5.9	)	$	(10.0	)	Net sales	$	1.6	$	2.7
Foreign exchange contracts	(0.5		)	0.4			Cost of products sold	0.3		0.1
Total	$	(6.4	)	$	(9.6	)		$	1.9	$	2.8